JPRN-UMIN000013405已完成未知
Evaluation of the efficacy, safety and injection interval of intravitreal injection of aflibercept for central retinal vein occlusion - intravitreal injection of aflibercept for central retinal vein occlusion
Department of Ophthalmology, Shiga University of Medical Science0 个研究点目标入组 50 人开始时间: 2014年3月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •severe renal disease unstable angina malignant arrhythmia history of brain infarction history of cerebral hemorrhage severe hypertension
研究者
相似试验
已完成
不适用
Evaluation of the efficacy, safety and injection interval of intravitreal injection of aflibercept for branch retinal vein occlusiobranch retinal vein occlusionJPRN-UMIN000018999Department of Ophthalmology, Shiga University of Medical Science40
已完成
不适用
Evaluation of the efficacy, safety and injection interval of intravitreal injection of aflibercept for age-related macular degeneratioage-related macular degenerationJPRN-UMIN000019028Department of Ophthalmology, Shiga University of Medical Science40
已完成
不适用
Evaluation of the efficacy, safety and injection interval of intravitreal injection of ranibizumab for retinal vein occlusioretinal vein occlusionJPRN-UMIN000012038Department of Ophthalmology, Shiga University of Medical Science50
招募中
1 期
Investigating the effect of stromal/mesenchymal stem cell-derived exosomes in patients with perianal fistulaAnal fistulaIRCT20240128060828N1Tehran University of Medical Sciences30
招募中
2 期
Evaluation of an injectable solution with the brand name ®Embella in order to reduce submental fat.Submental fat.IRCT20190210042676N29Zist orchid pharmed Company20